Literature DB >> 15714592

Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.

Marcus Bettstetter1, Matthias Woenckhaus, Peter J Wild, Petra Rümmele, Hagen Blaszyk, Arndt Hartmann, Ferdinand Hofstädter, Wolfgang Dietmaier.   

Abstract

Maspin, a member of the serpin family, has been reported to suppress metastasis and angiogenesis in breast and prostate cancers. Overexpression of maspin was associated with adverse prognostic features in several other tumours. In this study, expression of maspin was analysed in 41 colorectal carcinomas with high-frequency microsatellite instability (MSI-H) and 159 microsatellite stable colorectal cancers (MSS/MSI-L) by immunohistochemistry (IHC) and partly by relative quantitative real-time RT-PCR and western blot analyses. Significant upregulation of maspin expression was found in MSI-H tumours compared to both MSS/MSI-L tumours and matched benign colonic mucosa. Increased maspin expression was also found in three MSI-H colon cancer cell lines, but not in three MSS colon cancer cell lines by RT-PCR and western blot analyses. Regulation of maspin expression depended on promoter methylation as tissue specimens and cell lines expressing maspin showed unmethylated maspin promoters, whereas promoter hypermethylation was found in specimens with loss of maspin expression. Intense nuclear maspin immunostaining was seen specifically in MSI-H tumours (p = 0.013), de-differentiated tumours (p = 0.006), and at the invasion front. These findings provide new insights into the role of maspin in colorectal cancer progression and may be useful for diagnosis and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714592     DOI: 10.1002/path.1732

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  27 in total

Review 1.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

2.  Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer.

Authors:  Efthimia Tsoli; Petros K Tsantoulis; Alexandros Papalambros; Branko Perunovic; David England; David A Rawlands; Gary M Reynolds; Dimitrios Vlachodimitropoulos; Susan L Morgan; Chara A Spiliopoulou; Thanos Athanasiou; Vassilis G Gorgoulis
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

Review 3.  Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis.

Authors:  Jason Brocato; Max Costa
Journal:  Crit Rev Toxicol       Date:  2013-07       Impact factor: 5.635

4.  Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.

Authors:  Jung Ho Kim; Nam-Yun Cho; Jeong Mo Bae; Kyung-Ju Kim; Ye-Young Rhee; Hye Seung Lee; Gyeong Hoon Kang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Effect of epigenetic modification of maspin on extravillous trophoblastic function.

Authors:  Xinwei Shi; Yuanyuan Wu; Haiyi Liu; Xun Gong; Hui Du; Yuqi Li; Jun Zhao; Ping Chen; Guiju Tang; Fuyuan Qiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

Review 6.  Maspin: the new frontier.

Authors:  Zhila Khalkhali-Ellis
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

7.  Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.

Authors:  Matthias Woenckhaus; Lukas Bubendorf; Peter Dalquen; Julia Foerster; Hagen Blaszyk; Martina Mirlacher; Markus Soler; Wolfgang Dietmaier; Guido Sauter; Arndt Hartmann; Peter J Wild
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

8.  Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.

Authors:  Dengfeng Cao; Robb E Wilentz; James L Abbruzzese; Linus Ho; Anirban Maitra
Journal:  Int J Gastrointest Cancer       Date:  2005

9.  TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.

Authors:  Anna Manawapat-Klopfer; Louise T Thomsen; Peter Martus; Christian Munk; Rainer Russ; Hans Gmuender; Kirsten Frederiksen; Juliane Haedicke-Jarboui; Frank Stubenrauch; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2016-07-01       Impact factor: 6.166

10.  Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer.

Authors:  Maria de Leon; Horacio Cardenas; Edyta Vieth; Robert Emerson; Matthew Segar; Yunlong Liu; Kenneth Nephew; Daniela Matei
Journal:  Gynecol Oncol       Date:  2016-06-30       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.